Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Cigna / Yesintek Ustekinumab Kfce Subcutaneous Injection

Yesintek Ustekinumab Kfce Subcutaneous Injection — Cigna

4 indications indexed for this drug.

Crohn S Disease Moderate To Severe Active
View coverage criteria
Plaque Psoriasis Moderate To Severe
View coverage criteria
Psoriatic Arthritis Active
View coverage criteria
Ulcerative Colitis Moderate To Severe Active
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.